Financial reports
10-Q
2024 Q1
Quarterly report
9 May 24
ARS
2023 FY
Annual report to shareholders
28 Mar 24
10-K
2023 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
ARS
2022 FY
Annual report to shareholders
19 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
29 Mar 23
Current reports
8-K
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
9 May 24
8-K
Departure of Directors or Certain Officers
8 May 24
8-K
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results
19 Mar 24
8-K
Other Events
19 Jan 24
8-K
Departure of Directors or Certain Officers
20 Dec 23
8-K
Entry into a Material Definitive Agreement
6 Dec 23
8-K
Coya Therapeutics, Inc. Provides Business Update and Reports Q3 2023 Unaudited Financial Results
8 Nov 23
8-K
Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, joins Coya’s Board of Directors
21 Aug 23
8-K
Coya Therapeutics, Inc. Provides Business Update and Reports Q2 2023 Unaudited Financial Results
8 Aug 23
8-K
Departure of Directors or Certain Officers
14 Jul 23
Registration and prospectus
424B3
Prospectus supplement
16 Jan 24
S-3
Shelf registration
4 Jan 24
D
$26.48 mm in equity / options / securities to be acquired, sold $26.48 mm, 122 investors
20 Dec 23
424B4
Prospectus supplement with pricing info
12 May 23
POS AM
Prospectus update (post-effective amendment)
8 May 23
S-8
Registration of securities for employees
14 Apr 23
424B4
Prospectus supplement with pricing info
30 Dec 22
8-A12B
Registration of securities on exchange
27 Dec 22
S-1/A
IPO registration (amended)
12 Dec 22
FWP
Free writing prospectus
6 Dec 22
Other
EFFECT
Notice of effectiveness
16 Jan 24
CORRESP
Correspondence with SEC
10 Jan 24
UPLOAD
Letter from SEC
9 Jan 24
EFFECT
Notice of effectiveness
11 May 23
CERT
Certification of approval for exchange listing
29 Dec 22
EFFECT
Notice of effectiveness
29 Dec 22
SEC STAFF LETTER
SEC staff letter
28 Dec 22
CORRESP
Correspondence with SEC
23 Dec 22
CORRESP
Correspondence with SEC
23 Dec 22
CORRESP
Correspondence with SEC
13 Dec 22